Clinical Trial Update: The KEN SHE Study on HPV-vaccine Efficacy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on the KEN SHE study evaluating HPV-vaccine efficacy for papillomavirus infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papillomavirus Infections

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Papillomavirus Infections | Phase 4 | Status: UNKNOWN